Yanan Han

Title: Inventor Yanan Han: Pioneering Cancer Treatment Innovations

Introduction

Yanan Han is a distinguished inventor based in Shanghai, China, known for his significant contributions to the field of medicinal chemistry. With a focus on developing innovative compounds for cancer treatment, Han has secured two patents that underline his expertise and commitment to advancing treatment options for patients.

Latest Patents

Yanan Han's latest innovations include two pivotal patents concerning substituted pyrimidines as cyclin-dependent kinase inhibitors. The first patent describes a substituted pyridine compound and its pharmaceutically acceptable variants, which have shown potential in cancer treatment. The second patent introduces a nitrogen-containing fused heterocyclic compound, characterized by its high selectivity and inhibitory activity against CDK4 and CDK6. This compound is notable for its effectiveness against breast cancer cells, showcasing significant inhibition of tumor cell proliferation that is associated with cyclin-dependent kinase activity. Additionally, it demonstrates good stability concerning human or mouse liver microsomes, alongside a high bioavailability and favorable druggability in animal models.

Career Highlights

Currently, Yanan Han is employed at Shanghai Pharmaceuticals Holding Co., Ltd., where he continues to leverage his knowledge and skills in the development of pharmaceutical innovations. His work not only aids in creating effective cancer treatment options but also enhances the pharmaceutical landscape in China and beyond.

Collaborations

Throughout his career, Yanan has collaborated with notable coworkers such as Guangxin Xia and Qian Wang. These partnerships have fostered a creative environment conducive to innovation, leading to the development of advanced therapeutic solutions in his field.

Conclusion

Yanan Han stands out as an influential figure in the realm of cancer research and drug development. His innovative patents reflect his dedication to finding new ways to combat cancer, which can potentially improve patient outcomes. With ongoing research and collaboration, he is poised to make further impactful contributions to the medical community.